Showing results (1201-1210 of 2,471) with videos related to

Sort By:
Pageof 248
ACS Infectious Diseases|September 11, 2026
Fluorescent Farnesyl-Derived Probes Reveal Distinct Intracellular Localization Associated with Morphogenesis Suppression in Candida albicansIvan Voronov, Melissa Shbeta, Micha Fridman
ACS Infectious Diseases|September 11, 2026
Activity Refinement and Property Assessment of Peptidomimetics with Potent Antimalarial Activity That Target Plasmepsin VGregory L Adams, Madeline G Dans, Qingmiao Zhou, et al.
ACS Infectious Diseases|September 11, 2026
A Pathogen-Hopping Approach for the Identification of Compounds with Multistage Antischistosomal ActivityMalcolm G Taylor, Priscilla Mendonca Matos Day, Kristin Lees, et al.
ACS Infectious Diseases|October 26, 2022
A Bifunctional Chemical Reporter for in Situ Analysis of Cell Envelope Glycan Recycling in MycobacteriaAmol Arunrao Pohane, Devin J Moore, Irene Lepori, et al.
ACS Infectious Diseases|June 14, 2016
Dipeptide-Based Metabolic Labeling of Bacterial Cells for Endogenous Antibody RecruitmentJonathan M Fura, Sean E Pidgeon, Morgan Birabaharan, et al.
ACS Infectious Diseases|August 19, 2015
High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus ReplicationMegan R Edwards, Colette Pietzsch, Thibaut Vausselin, et al.
ACS Infectious Diseases|January 29, 2016
Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel)Joëlle Jourdan, Hugues Matile, Ellen Reift, et al.
ACS Infectious Diseases|January 26, 2016
High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway SignalingKate Hartland, Jun Pu, Michelle Palmer, et al.
ACS Infectious Diseases|March 22, 2016
Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?Emanuele Amata, Hualin Xi, Gonzalo Colmenarejo, et al.
ACS Infectious Diseases|May 27, 2016
Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ MiceScott M Irwin, Brendan Prideaux, Edward R Lyon, et al.
Pageof 248